Entries by PR Newswire

, , , , , , , ,

Janssen Submits Application to U.S. FDA Seeking Approval of Amivantamab

The Janssen Pharmaceutical Companies of Johnson & Johnson submitted a Biologics License Application to the U.S. Food and Drug Administration seeking approval of amivantamab for the treatment of patients with metastatic non-small cell lung cancer with epidermal growth factor receptor exon 20 insertion mutations whose disease has progressed on or after platinum-based chemotherapy.

, , , , , , ,

Vitas Healthcare Selects GTO Group For Marketing, Branding & Industry Initiatives

Vitas Healthcare chose Greater Than One (GTO) Group as agency of record to support the hospice company’s transformative focus on brand equity, improved efficiency and enhanced return on investment from its marketing initiatives.